Methods and compositions for cancer therapy
US7807647B2 · kind B2 · utility
12Cited by
8References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 22, 2005 |
| Grant date | Oct 5, 2010 |
| Priority date | — |
| Expiry date | Aug 23, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/711
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to methods and compositions for the inhibition of gene expression. In particular, the present invention provides oligonucleotide-based therapeutics for the inhibition of oncogenes involved in cancers.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.